Headlines

    Weight-loss Injections Prove Effective: 40% of Indians Lose 10% of Their Body Weight | India News

    Weight-loss Injections Prove Effective: 40% of Indians Lose 10% of Their Body Weight | India News

    Are you from India? 🇮🇳

    👉 Check Today's Deals on Amazon India

    Weight-Loss Injections: A Promising Solution for Indians

    Increased Popularity in India

    New weight-loss injections, already popular around the world, are showing remarkable results among Indian patients. A recent study from a Delhi hospital revealed that over 40% of individuals lost at least 10% of their body weight—an achievement that can significantly enhance overall health.

    Study Insights from Max Super Specialty Hospital

    Conducted by endocrinologist Dr. Ambrish Mithal and his team at Max Super Specialty Hospital, Saket, the research was published in the Indian Journal of Endocrinology and Metabolism. It tracked 150 overweight and obese adults undergoing these weight-loss therapies in routine clinical practice.

    On average, patients experienced an 8% reduction in their body weight over six months—equating to a loss of approximately 6 to 10 kilos for many. Notably, nearly 75% of participants lost at least 5%, which is considered the minimum threshold for health benefits such as improved sugar control and reduced heart risk.

    Long-Term Expectations and Individual Variability

    Experts caution that these findings are based on a short-term follow-up of around six months. Dr. Mithal noted, “This is not the final weight loss. With longer follow-up, especially at one year, the reduction is likely to be significantly greater.”

    However, the weight-loss outcomes varied among participants. Those without diabetes fared significantly better, losing nearly double the weight compared to diabetic patients. This difference may be attributed to deeper metabolic changes and issues related to insulin resistance common in diabetes.

    The Impact of Medication Type

    The type of medication administered also played a crucial role. Patients using tirzepatide—a new dual-action injection—saw more rapid and significant weight loss compared to those on semaglutide. Many individuals reached the 10% weight-loss mark within 9 to 10 months, though medical professionals emphasize that such progress is gradual rather than instantaneous.

    Results Based on Patient Characteristics

    The study uncovered that younger patients and those using these injections for the first time often observed quicker weight-loss results. In contrast, individuals with prior experience using similar medications lost weight at a slower pace.

    While side effects such as nausea, bloating, and constipation were common—particularly in the initial stages—these effects were manageable and typically did not necessitate discontinuation of treatment.

    Real-World Application and Effectiveness

    Unlike tightly controlled clinical trials, this study reflects real-life conditions where participants may miss doses, alter their diets, or have pre-existing health conditions. Nonetheless, the results remained consistent, providing physicians with confidence in the efficacy of these medications beyond ideal circumstances.

    A Shift in Weight Loss Strategies

    With rising rates of obesity and diabetes in India, these findings signal a shift from traditional weight-loss methods focused solely on diet and exercise to including medical support that can yield measurable results.

    Conclusion: The Path to Meaningful Weight Loss

    Experts emphasize that weight-loss injections are not quick fixes; rather, they work best when combined with consistent lifestyle changes. When approached holistically, these medications can contribute to steady, meaningful weight-loss outcomes over time.

    Are you from USA? 🇺🇸

    🎁 Check Best Christmas Deals

    Limited Time Holiday Offers



    Source link

    Leave a Reply

    Your email address will not be published. Required fields are marked *